EAN News

Symposium 5: Spectrum of dementias  18 June 2018  By Martin Rakusa  The symposium was chaired by Prof. Jonathan M. Schott from London, United Kingdom, and Prof. Evelien Lemstra from Amsterdam, The Netherlands. Aim of the symposium was to cover four… Continue Reading

The newly elected delegates representing the full members and delegates appointed newly by their national societies met for the first time in Lisbon during the annual meeting of the EAN. This assembly has been elected (or appointed) for the next 4 years, and will meet again in Oslo (2019), Paris (2010) and Vienna (2021).

Sofia Duque (EuGMS – European Geriatric Medicine Societies), Paul Boon and David B. Vodusek (EAN) met during the EAN congress to intensify the between the two organisations. The goal is to improve the care and research of elderly neurological patients… Continue Reading

Overarching Theme: Molecular and genetic therapies for neurogenetic disorders   18 June 2018   By Tom Jenkins   This plenary session focused on perhaps the most exciting area of clinical neurology in recent years, at least in terms of therapeutic breakthroughs and… Continue Reading

Dr Münevver Ece Güven, from Istanbul, Turkey, became the 1000th full individual member of the EAN during the meeting and received from Prof. Didier Leys, General Secretary, a unique offer of 1-year free subscription to the European Journal of Neurology, on top of the other privileges of full members.

The inaugural EAN Brain Challenge, hosted by Prof. Marie Vidailhet and Prof. Angelo Antonini, pitted a local Portuguese team against an international team, including members from Germany, Italy, Romania and Ireland, answering case-based questions posed by the various scientific panels, graded according to difficulty.

CME Topical symposium: Digital outcome assessment The symposium of digital outcome assessment had the aim to discuss objective measures performed by innovative digital techniques in different neurological diseases. Prof. Kappos started the symposium discussing about the “neurostatus-eEDSS” digitally measured in… Continue Reading

In recent years, much progress was made in understanding progressive MS bringing therapeutic options within sight. In this plenary symposium, the most important insights were highlighted.

EAN/EAPC Symposium 4: Palliative care and neurology Chairpersons:
Paul Boon, Ghent, Belgium
Philip Larkin, Dublin, Ireland Palliative care from a neurologist’s perspective: the evidence
David Oliver, Canterbury, United Kingdom Guidelines in progress across Europe
Raymond Voltz, Cologne, Germany What can… Continue Reading

Symposium 3: EAN/ESO: Cerebral small vessel disease – recent advances and clinical implications It’s Monday afternoon. You are reviewing results from your general neurology clinic. You recently saw a rather anxious patient with worsening headaches, which sounded probably migrainous, but… Continue Reading

This symposium was chaired by Prof. Reetta K. Kälviäinen, Kuopio, Finland, and Prof. Hannah Cock, London, United Kingdom. Overall, the symposium updated us about the link between genetic and epilepsy, and outlined the benefits and controversies regarding the use of genetical test in epilepsy.

Prof. T. Fleming Outeiro, from Goettingen, Germany, gave a very interesting lecture about “Tau protein in normal and pathological brain”.  He lectured on the misfolding of tau protein and its effects.  Protein folding and homeostasis remain a constant challenge for the normal cell. Tau is a complex microtubule binding protein.

Prof. Günther Deuschl, President of the EAN, also welcomed everybody. He highlighted some recent important studies published by European researchers, the celebration of the Brain Prize in Europe, and some EAN achievements such as the guidelines project. The EAN is also particularly interested in assessing the burden of neurological diseases in Europe.